Search clinical trials for: lispro

Total 540 results

1
2
3
4
5
6
7
8
9
10
11
›

Wockhardt

Withdrawn

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

Bioequivalence in Healthy Subjects

United States
Michael Tsoukas
Adocia

Recruiting

Safety and Efficacy of BC LisPram

Type1 Diabetes Mellitus

Canada
Wockhardt

Withdrawn

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

Bioequivalence in Healthy Subjects

United States
Diasome Pharmaceuticlas, Inc.

Recruiting

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

Diabetes Mellitus, Type 1

United States
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
Adocia

Completed

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Healthy

Germany
Eli Lilly and Company

Completed

A Study of a New LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of Various Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

Diabetes Mellitus, Type 1

Germany
Adocia

Completed

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Diabetes Mellitus

Germany
Graydon Meneilly

Withdrawn

Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique

Diabetes Mellitus | Lipohypertrophy

Canada
Joslin Diabetes Center
Boston Children's Hospital

Completed

Insulin Bolus Required for High Fat Foods in Type 1 Diabetes

Type 1 Diabetes
Medical University of Graz
European Commission

Completed

Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations

Type 1 Diabetes

Austria
Eli Lilly and Company

Completed

Bioequivalence of Two Lispro Formulations

Healthy Volunteers

Singapore
Adocia
Eli Lilly and Company

Completed

A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants

Healthy Participants

Singapore
Diasome Pharmaceuticals
Integrium

Completed

Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1) (ISLE-1)

Type 1 Diabetes Mellitus

United States
University of Hull

Completed

Environmental Effects Type 1 Diabetes Mellitus

Type1diabetes

United Kingdom
University of British Columbia

Completed

Optimizing Insulin Absorption and Insulin Injection Technique in Older Adults

Diabetes

Canada
Eli Lilly and Company

Completed

A Study of Lispro Formulations in Healthy Participants

Healthy Volunteers

Singapore
Diasome Pharmaceuticals
Integrium

Completed

Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control

Diabetes Mellitus, Type 1

United States
Louisiana State University Health Sciences Center...
Acuity Center

Withdrawn

Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease

Mild Cognitive Impairment | Alzheimer's Disease

United States
Adocia
Eli Lilly and Company

Completed

An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

Healthy

Germany
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)

Type 1 Diabetes Mellitus

Spain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
Sun Yat-sen University

Completed

Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Manchester University NHS Foundation Trust

Recruiting

Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study) (ACOLYTE)

Diabetes Mellitus, Type 1

United Kingdom
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Diabetes Mellitus, Type 1

Germany
Biodel

Completed

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Type 1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes

Type 1 Diabetes

Germany
Eli Lilly and Company

Completed

Comparison of Insulin Mix25 Versus Mix50 (CLASSIFY)

Type 2 Diabetes Mellitus

Japan, Korea, Republic of, China, Turkey
Eli Lilly and Company

Completed

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Finland
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

Clamp Study

Russian Federation
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 Formulations in Healthy Participants

Healthy Volunteers

Singapore
Adocia
Eli Lilly and Company

Completed

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Completed

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Diabetes Mellitus, Type 2

Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
Inreda Diabetic B.V.

Completed

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes (FAST 1)

Type 1 Diabetes

Netherlands
Adocia

Completed

A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

Diabetes Mellitus Type 1

Germany
Adocia
Eli Lilly and Company

Completed

A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

Type 1 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Eli Lilly and Company

Completed

The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) (IOOV)

Diabetes Mellitus, Type 2

United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
Eli Lilly and Company

Completed

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Japan
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Healthy Participants

Healthy

Singapore
Sanofi

Completed

Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion

Type 1 Diabetes Mellitus

United States
Dance Biopharm Inc.
WCCT Global

Terminated

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Safety and Tolerability

United States
Tonghua Dongbao Pharmaceutical Co.,Ltd

Recruiting

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

Type 2 Diabetes

China
University of California, San Diego
The Leona M. and Harry B. Helmsley Charitable Trust

Not yet recruiting

Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes

Type 1 Diabetes

1
2
3
4
5
6
7
8
9
10
11
›

3

Subscribe